Celldex Therapeutics Balance Sheet (2010-2025) | CLDX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Accumulated Depreciation (Quarter)				21.13M				21.63M				22.39M				23.46M				23.90M
Receivables - Accured (Quarter)	0.40M	0.30M	0.80M	1.30M	0.80M	1.10M	0.70M	0.80M	0.60M	1.30M	1.20M	1.90M	4.70M	4.80M	5.30M	6.10M	6.00M	6.20M	6.00M	4.40M
Assets
Current Assets
Cash & Equivalents (Quarter)	69.31M	43.45M	72.18M	39.14M	25.29M	28.40M	18.58M	29.43M	54.12M	28.22M	21.13M	34.81M	115.08M	42.74M	36.40M	28.36M	17.14M	23.04M	36.04M	28.87M
Receivables - Net (Quarter)	1.83M	0.50M	0.20M	0.17M	0.24M	0.10M	0.19M	0.35M	1.31M	0.12M	0.25M	2.63M	2.67M	1.53M	0.85M	0.70M	1.06M	0.09M	0.09M	2.02M
Receivables (Quarter)	1.83M	0.50M	0.20M	0.17M	0.24M	0.10M	0.19M	0.35M	1.31M	0.12M	0.25M	2.63M	2.67M	1.53M	0.85M	0.70M	1.06M	0.09M	0.09M	2.02M
Prepaid Assets (Quarter)	3.59M	3.07M	3.27M	2.42M	9.99M	11.06M	10.94M	12.39M	9.90M	12.01M	10.33M	5.47M	8.81M	8.12M	21.99M	21.18M	19.40M	17.98M	21.03M	14.08M
Current Assets (Quarter)	181.50M	167.61M	426.56M	410.84M	390.70M	367.98M	334.60M	317.69M	289.60M	264.82M	245.93M	431.69M	835.32M	811.98M	778.84M	747.16M	693.76M	648.40M	604.34M	534.66M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	3.75M	3.50M	3.34M	3.55M	3.48M	3.74M	3.75M	3.75M	4.00M	3.94M	4.16M	4.06M	4.06M	3.86M	4.23M	4.35M	4.60M	4.39M	4.83M	5.33M
Long-Term Investments (Quarter)
Goodwill (Quarter)
Intangibles (Quarter)	30.70M	30.69M	27.19M	27.19M	27.20M	27.20M	27.20M	27.19M	27.20M	27.20M	27.20M	27.19M	27.19M	27.19M	27.20M	27.19M	27.20M	27.20M	27.20M	27.19M
Goodwill & Intangibles (Quarter)	30.70M	30.69M	27.19M	27.19M	27.20M	27.20M	27.20M	27.19M	27.20M	27.20M	27.20M	27.19M	27.19M	27.19M	27.20M	27.19M	27.20M	27.20M	27.20M	27.19M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.04M	0.04M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.11M	0.11M	0.11M	0.11M	0.11M	9.75M	9.75M	10.41M	9.30M	9.36M	13.36M
Non-Current Assets (Quarter)	37.57M	36.95M	33.65M	33.81M	33.34M	34.98M	34.63M	35.04M	34.92M	34.49M	34.32M	33.93M	33.52M	33.61M	44.34M	45.18M	45.71M	44.00M	44.10M	48.32M
Assets (Quarter)	219.06M	204.55M	460.20M	444.65M	424.04M	402.96M	369.23M	352.74M	324.52M	299.31M	280.26M	465.63M	868.85M	845.59M	823.18M	792.34M	739.47M	692.41M	648.44M	582.98M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.00M	0.69M	0.84M	1.23M	1.02M	0.90M	2.27M	3.34M	3.37M	0.88M	3.59M	3.49M	3.23M	3.80M	1.11M	3.27M	3.41M	2.07M	4.27M	1.18M
Payables (Quarter)	1.00M	0.69M	0.84M	1.23M	1.02M	0.90M	2.27M	3.34M	3.37M	0.88M	3.59M	3.49M	3.23M	3.80M	1.11M	3.27M	3.41M	2.07M	4.27M	1.18M
Accumulated Expenses (Quarter)	7.02M	7.85M	10.25M	7.97M	9.23M	11.23M	11.43M	12.84M	9.37M	12.26M	18.47M	9.35M	17.54M	18.59M	28.20M	33.84M	25.46M	28.42M	39.72M	47.03M
Other Accumulated Expenses (Quarter)	7.58M	4.62M	1.72M	0.28M	2.50M	1.39M	1.15M	0.99M	0.98M	0.98M	4.23M	0.38M	3.88M	3.67M	1.40M	0.94M	1.65M	0.93M	0.93M	1.23M
Short term Debt (Quarter)
Current Leases (Quarter)	1.37M	1.33M	1.37M	1.75M	1.80M	1.43M	1.44M	1.45M	1.49M	1.53M	1.55M	1.61M	1.64M	1.59M	1.38M	1.45M	1.50M	1.54M	1.55M	1.55M
Total Current Liabilities (Quarter)	16.98M	14.49M	14.18M	16.53M	14.56M	29.95M	16.29M	18.61M	15.22M	15.65M	27.84M	31.12M	26.29M	27.66M	32.09M	39.50M	32.02M	32.96M	46.47M	50.99M
Non-Current Liabilities
Non-Current Debt (Quarter)
Operating Leases (Quarter)	1.76M	1.45M	1.71M	1.30M	0.84M	2.59M	2.19M	2.59M	2.16M	1.73M	1.30M	0.93M	0.47M	0.80M	1.71M	2.36M	1.93M	1.50M	1.07M	0.78M
Other Non-Current Liabilities (Quarter)	6.16M	6.33M	7.60M	7.35M	10.54M	5.33M	5.33M	5.33M	4.40M	4.40M	4.40M	4.40M	3.47M	3.47M	3.47M	3.47M	2.54M	2.54M	2.54M	4.04M
Total Non-Current Liabilities (Quarter)	18.74M	15.93M	15.89M	17.82M	15.40M	32.53M	18.48M	21.20M	17.38M	17.37M	29.14M	32.05M	26.76M	28.45M	33.80M	41.86M	33.95M	34.46M	47.53M	51.77M
Total Liabilities (Quarter)	24.90M	22.27M	23.49M	25.18M	25.94M	37.87M	23.81M	26.53M	21.78M	21.77M	33.54M	36.46M	30.23M	31.93M	37.27M	45.34M	36.49M	37.00M	50.08M	55.82M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	194.17M	182.28M	436.71M	419.48M	398.10M	365.09M	345.42M	326.20M	302.74M	277.54M	246.72M	429.17M	838.61M	813.66M	785.90M	747.00M	702.98M	655.41M	598.36M	527.16M
Shareholder's Equity (Quarter)	194.17M	182.28M	436.71M	419.48M	398.10M	365.09M	345.42M	326.20M	302.74M	277.54M	246.72M	429.17M	838.61M	813.66M	785.90M	747.00M	702.98M	655.41M	598.36M	527.16M
Liabilities and Shareholders Equity (Quarter)	219.06M	204.55M	460.20M	444.65M	424.04M	402.96M	369.23M	352.74M	324.52M	299.31M	280.26M	465.63M	868.85M	845.59M	823.18M	792.34M	739.47M	692.41M	648.44M	582.98M
Retained Earnings (Quarter)	-1089.63M	-1103.01M	-1123.46M	-1143.61M	0.11M	-1202.66M	-0.11M	1.26M	2.12M	-1315.80M	2.13M	3.31M	2.24M	-1466.01M	5.29M	-1555.22M	-1609.02M	3.34M	3.77M	3.63M
Treasury Shares (Quarter)
Shares Outstanding (Quarter)	39.61M	39.62M	46.66M	46.73M	46.75M	46.76M	47.10M	47.20M	47.24M	47.25M	47.26M	55.88M	65.91M	66.28M	66.34M	66.37M	66.38M	66.39M	66.45M	66.55M

Research Tools

Celldex Therapeutics Balance Sheet (2010-2025) | CLDX

Create an account

Sign In

Reset Password